Stay ahead in the medical device industry by understanding the FDA’s classification of computerized behavioral therapy devices for fibromyalgia symptoms. This course provides targeted insights into the De Novo process, class II special controls, and step-by-step compliance requirements. Learn how to meet clinical data, software validation, and labeling standards, while ensuring your device achieves market access and maintains patient safety. Gain practical, actionable guidance tailored to device manufacturers, regulatory professionals, and healthcare innovators.
In this course you will learn the following:
* Understand the FDA’s classification process for new medical devices, specifically the De Novo pathway.
* Identify the key requirements and special controls for computerized behavioral therapy devices for fibromyalgia.
* Implement the necessary steps to ensure compliance with class II classification and special controls.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
